Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05649176 · ClinicalTrials.gov registry record · NA

Lifestyle Intervention for Improving Insulin Resistance and Concern for Health

A NA study, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT05649176: Completed NA study, sponsored by Pennington Biomedical Research Center.

NCT05649176 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05649176, a NA study, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The primary objective of this study is to test the effect of a diet and exercise program in older adults with insulin resistance and a motivation disorder known as apathy. The main questions the study aims to answer are: 1. Does the diet and exercise program improve insulin resistance and apathy? 2. Does the addition of soybean to the diet enhance the effect? Participants will be given all meals for 12 weeks and will exercise under supervision. They will undergo a test of insulin sensitivity and complete questionnaires. Researchers will compare the groups given: 1. A diet to moderate the blood glucose response that contains soybean; and 2. A diet to moderate the blood glucose response that does not contain soybean.

Primary Outcome

Insulin sensitivity will measured in a hyperinsulinemic euglycemic clamp test

Interventions

  • OTHER Diet without soy
  • OTHER Diet with soy

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-02-13
Est. Completion 2025-10-27
Phase NA

What the finished NCT05649176 record still lists

NCT05649176 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Diet without soy is the first listed.

NCT05649176 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05649176 about?

NCT05649176 is a clinical study titled "Lifestyle Intervention for Improving Insulin Resistance and Concern for Health". The primary objective of this study is to test the effect of a diet and exercise program in older adults with insulin resistance and a motivation disorder known as apathy. The main questions the study aims to answer are: 1. Does the diet and exercise program improve insulin resistance and apathy? 2...

What is the current status of trial NCT05649176?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-02-13. Estimated completion is 2025-10-27.

What interventions are being tested in trial NCT05649176?

The interventions under investigation include: Diet without soy (OTHER), Diet with soy (OTHER).

Who is sponsoring clinical trial NCT05649176?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05649176's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05649176, the US trial registry maintained by the National Library of Medicine. NCT05649176 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.